Published • loading... • Updated
Biontech's Major Shareholder Anticipates Early Board Replacement
Summary by Berliner-sonntagsblatt.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
One of the major shareholders and co-founders of Biontech, Thomas Strüngmann, anticipates an early replacement on the board of directors of the Mainz biotech company. "The appointment of a new medical director will not take long," said Strüngmann of the "Frankfurter Allgemeine Sonntagszeitung" (FAS). The position becomes vacant because the previous medical director Özlem Türeci, just like her husband Ugur Sahin, has announced her retirement from…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
